vs

Side-by-side financial comparison of CME Group (CME) and Palantir Technologies (PLTR). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.4B, roughly 1.3× Palantir Technologies). Palantir Technologies runs the higher net margin — 43.3% vs 0.1%, a 43.2% gap on every dollar of revenue. On growth, Palantir Technologies posted the faster year-over-year revenue change (70.0% vs 14.5%). Over the past eight quarters, Palantir Technologies's revenue compounded faster (48.9% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Palantir Technologies Inc. is an American publicly traded company that develops data integration and analytics platforms enabling government agencies, militaries, and corporations to combine and analyze data from multiple sources. Its flagship products—Gotham and Foundry —connect previously siloed databases to support intelligence operations, counterterrorism analysis, law enforcement, and enterprise analytics.

CME vs PLTR — Head-to-Head

Bigger by revenue
CME
CME
1.3× larger
CME
$1.9B
$1.4B
PLTR
Growing faster (revenue YoY)
PLTR
PLTR
+55.5% gap
PLTR
70.0%
14.5%
CME
Higher net margin
PLTR
PLTR
43.2% more per $
PLTR
43.3%
0.1%
CME
Faster 2-yr revenue CAGR
PLTR
PLTR
Annualised
PLTR
48.9%
10.8%
CME

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
PLTR
PLTR
Revenue
$1.9B
$1.4B
Net Profit
$1.2M
$608.7M
Gross Margin
84.6%
Operating Margin
0.1%
40.9%
Net Margin
0.1%
43.3%
Revenue YoY
14.5%
70.0%
Net Profit YoY
20.7%
670.4%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
PLTR
PLTR
Q1 26
$1.9B
Q4 25
$1.6B
$1.4B
Q3 25
$1.5B
$1.2B
Q2 25
$1.7B
$1.0B
Q1 25
$1.6B
$883.9M
Q4 24
$1.5B
$827.5M
Q3 24
$1.6B
$725.5M
Q2 24
$1.5B
$678.1M
Net Profit
CME
CME
PLTR
PLTR
Q1 26
$1.2M
Q4 25
$1.2B
$608.7M
Q3 25
$908.0M
$475.6M
Q2 25
$1.0B
$326.7M
Q1 25
$956.2M
$214.0M
Q4 24
$874.6M
$79.0M
Q3 24
$912.8M
$143.5M
Q2 24
$883.2M
$134.1M
Gross Margin
CME
CME
PLTR
PLTR
Q1 26
Q4 25
84.6%
Q3 25
82.4%
Q2 25
80.8%
Q1 25
80.4%
Q4 24
78.9%
Q3 24
79.8%
Q2 24
81.0%
Operating Margin
CME
CME
PLTR
PLTR
Q1 26
0.1%
Q4 25
61.8%
40.9%
Q3 25
63.3%
33.3%
Q2 25
66.7%
26.8%
Q1 25
67.5%
19.9%
Q4 24
62.1%
1.3%
Q3 24
64.6%
15.6%
Q2 24
65.3%
15.5%
Net Margin
CME
CME
PLTR
PLTR
Q1 26
0.1%
Q4 25
71.7%
43.3%
Q3 25
59.1%
40.3%
Q2 25
60.6%
32.6%
Q1 25
58.2%
24.2%
Q4 24
57.3%
9.5%
Q3 24
57.6%
19.8%
Q2 24
57.6%
19.8%
EPS (diluted)
CME
CME
PLTR
PLTR
Q1 26
Q4 25
$3.24
$0.24
Q3 25
$2.49
$0.18
Q2 25
$2.81
$0.13
Q1 25
$2.62
$0.08
Q4 24
$2.40
$0.03
Q3 24
$2.50
$0.06
Q2 24
$2.42
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
PLTR
PLTR
Cash + ST InvestmentsLiquidity on hand
$2.4B
$7.2B
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$7.4B
Total Assets
$202.0B
$8.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
PLTR
PLTR
Q1 26
$2.4B
Q4 25
$4.5B
$7.2B
Q3 25
$2.6B
$6.4B
Q2 25
$2.1B
$6.0B
Q1 25
$1.5B
$5.4B
Q4 24
$3.0B
$5.2B
Q3 24
$2.4B
$4.6B
Q2 24
$1.9B
$4.0B
Total Debt
CME
CME
PLTR
PLTR
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
PLTR
PLTR
Q1 26
Q4 25
$28.7B
$7.4B
Q3 25
$28.2B
$6.6B
Q2 25
$27.7B
$5.9B
Q1 25
$27.0B
$5.4B
Q4 24
$26.5B
$5.0B
Q3 24
$28.2B
$4.5B
Q2 24
$27.6B
$4.1B
Total Assets
CME
CME
PLTR
PLTR
Q1 26
$202.0B
Q4 25
$198.4B
$8.9B
Q3 25
$187.1B
$8.1B
Q2 25
$179.9B
$7.4B
Q1 25
$157.8B
$6.7B
Q4 24
$137.4B
$6.3B
Q3 24
$137.8B
$5.8B
Q2 24
$123.4B
$5.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
PLTR
PLTR
Operating Cash FlowLast quarter
$777.3M
Free Cash FlowOCF − Capex
$764.0M
FCF MarginFCF / Revenue
54.3%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
1.28×
TTM Free Cash FlowTrailing 4 quarters
$2.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
PLTR
PLTR
Q1 26
Q4 25
$1.1B
$777.3M
Q3 25
$968.1M
$507.7M
Q2 25
$1.1B
$539.3M
Q1 25
$1.1B
$310.3M
Q4 24
$1.0B
$460.3M
Q3 24
$1.0B
$419.8M
Q2 24
$776.9M
$144.2M
Free Cash Flow
CME
CME
PLTR
PLTR
Q1 26
Q4 25
$1.1B
$764.0M
Q3 25
$949.7M
$500.9M
Q2 25
$1.0B
$531.6M
Q1 25
$1.1B
$304.1M
Q4 24
$991.7M
$457.2M
Q3 24
$973.2M
$415.8M
Q2 24
$758.7M
$141.3M
FCF Margin
CME
CME
PLTR
PLTR
Q1 26
Q4 25
66.8%
54.3%
Q3 25
61.8%
42.4%
Q2 25
61.5%
53.0%
Q1 25
67.1%
34.4%
Q4 24
65.0%
55.3%
Q3 24
61.4%
57.3%
Q2 24
49.5%
20.8%
Capex Intensity
CME
CME
PLTR
PLTR
Q1 26
Q4 25
2.0%
0.9%
Q3 25
1.2%
0.6%
Q2 25
1.1%
0.8%
Q1 25
0.9%
0.7%
Q4 24
1.7%
0.4%
Q3 24
1.9%
0.5%
Q2 24
1.2%
0.4%
Cash Conversion
CME
CME
PLTR
PLTR
Q1 26
Q4 25
0.96×
1.28×
Q3 25
1.07×
1.07×
Q2 25
1.03×
1.65×
Q1 25
1.17×
1.45×
Q4 24
1.16×
5.83×
Q3 24
1.10×
2.92×
Q2 24
0.88×
1.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

PLTR
PLTR

Geographic Concentration Risk$1.1B77%
Other$330.4M23%

Related Comparisons